The medication essentially provides ongoing support for the biological changes that improve diabetes control and weight management
While semaglutide's effect on gastric emptying can theoretically alter the absorption of orally administered drugs, FDA studies have found no clinically relevant pharmacokinetic interactions with several commonly tested medications
doi:10.1016/s0033-0620(97)80037-0 Fisher JS, Gao J, Han DH, Holloszy JO, Nolte LA
Its mechanism centers on GLP-1 receptor activation in the pancreas (enhancing glucose-dependent insulin secretion and suppressing glucagon), the stomach (delaying gastric emptying), and the hypothalamus (reducing appetite via effects on satiety-signaling neurons)
Clinical evidence The 2013 exenatide proof-of-concept clinical trial involving 45 moderate PD patients displayed possible efficacy concerning part 3 of the Movement Disorders Society Unified Parkinsons Disease Rating Scale (MDS-UPDRS) [17]
Without water, the risk of hydrolysis or microbial growth is minimized